BioNxt Solutions Inc. (CSE: BNXT)(OTCQB: BNXTF)(FSE: BXT) signed a letter agreement with an unnamed European chemotherapy company to acquire exclusive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE